Myokardia Inc Headquarters
The links below provide all the necessary information about Myokardia Inc Headquarters. Also there you will find information about the address, phone numbers, emails and much more.
MyoKardia Corporate Headquarters, Office Locations and Address…
- https://craft.co/myokardia/locations#:~:text=MyoKardia%20is%20headquartered%20in%20South%20San%20Francisco%2C%20CA,View%20Company%20Filter%20locations%20by%20country%20United%20States
- none
Myokardia, Inc. Company Profile | Brisbane, CA
- https://www.dnb.com/business-directory/company-profiles.myokardia_inc.c0afa10ecd900deca0e7c475dd322573.html
- Company Description: Myokardia, Inc. is located in Brisbane, CA, United States and is part of the Pharmaceutical and Medicine Manufacturing Industry. Myokardia, Inc. has 235 total employees across all of its locations and generates $33.56 million in sales (USD). (Sales figure is estimated).
MyoKardia Corporate Headquarters, Office Locations and …
- https://craft.co/myokardia/locations
- MyoKardia is headquartered in South San Francisco, CA and has 2 office locations across 1 country. View Company Filter locations by country United States Discover additional companies by location with Advanced Search in Craft Learn more All MyoKardia Locations South San Francisco (HQ), CA United States 333 Allerton Ave Brisbane, CA United States
MyoKardia Company Profile - Craft
- https://craft.co/myokardia
- MyoKardia is a company that discovers, develops, and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases. MyoKardia was founded in 2012 and is headquartered in South San Francisco, CA, US Report incorrect company information
MyoKardia - Crunchbase Company Profile & Funding
- https://www.crunchbase.com/organization/myokardia
- Headquarters Regions San Francisco Bay Area, West Coast, Western US Founded Date Sep 2012 Founders Christine Seidman, James Spudich, Jonathan Seidman, Leslie Leinwand Operating Status Closed Last Funding Type Series B Legal Name MyoKardia, Inc. Stock Symbol NASDAQ:MYOK Company Type For Profit Contact Email [email protected]
MyoKardia | LinkedIn
- https://www.linkedin.com/company/myokardia
- 201-500 employees Headquarters Brisbane, California Type Public Company Founded 2012 Specialties Genetic Heart Disease, Cardiomyopathy, …
MyoKardia Inc - Company Profile and News - Bloomberg …
- https://www.bloomberg.com/profile/company/MYOK:US
- MyoKardia, Inc. operates as a precision cardiovascular medicine company. The Company develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular...
MyoKardia Company Profile: Acquisition & Investors
- https://pitchbook.com/profiles/company/55285-12
- Contact Information Website www.myokardia.com Ownership Status Acquired/Merged Financing Status Formerly VC-backed Primary Industry Drug Discovery Other Industries Biotechnology Other Pharmaceuticals and Biotechnology Acquirer Bristol-Myers Squibb Primary Office 1000 Sierra Point Parkway Brisbane, CA 94005 United States
SEC.gov | MyoKardia, Inc.
- https://www.sec.gov/myokardia-inc
- MyoKardia, Inc. Feb. 5, 2018 Downloads. pdf 18-00925-T.pdf (444.38 KB) Modified: Feb. 5, 2018 STAY CONNECTED 1 Twitter 2 Facebook 3 RSS 4 YouTube 6 LinkedIn 8 Email Updates. About The SEC. Budget & Performance; Careers; Commission Votes; Contact; Contracts; Data Resources; ...
Bristol Myers Squibb acquires MyoKardia, expanding its …
- https://bsmac.org/2021/03/01/bristol-myers-squibb-acquires-myokardia-expanding-its-cardiovascular-portfolio/
- Bristol Myers Squibb is a global biopharmaceutical company headquartered in New York City engaged in discovering, developing and delivering innovative treatments to treat patients with serious diseases. In particular, the company’s pharmaceutical products include synthesized drugs or small molecules, as well as products achieved through biologics.
Bristol Myers Squibb Completes Acquisition of …
- https://news.bms.com/news/details/2020/Bristol-Myers-Squibb-Completes-Acquisition-of-MyoKardia-Strengthening-Companys-Leading-Cardiovascular-Franchise/default.aspx
- Bristol Myers Squibb Completes Acquisition of MyoKardia, Strengthening Company’s Leading Cardiovascular Franchise NEW YORK-- (BUSINESS WIRE)-- Bristol Myers Squibb (NYSE:BMY) announced today that it has successfully completed its acquisition of MyoKardia, Inc. in an all cash transaction for approximately $13.1 billion.
MYOKARDIA, INC. : Shareholders Board Members Managers and …
- https://www.marketscreener.com/quote/stock/MYOKARDIA-INC-24749772/company/
- MyoKardia, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the treatment of heritable cardiomyopathies, a group of rare, genetically-driven forms of heart failure that result from biomechanical defects in cardiac muscle contraction. The Company is engaged in the business of developing and commercializing therapeutics.
Bristol Myers Squibb to Acquire MyoKardia for $13.1 Billion in Cash
- https://news.bms.com/news/details/2020/Bristol-Myers-Squibb-to-Acquire-MyoKardia-for-13.1-Billion-in-Cash/default.aspx
- You may read and copy any reports, statements or other information filed by Bristol Myers Squibb or MyoKardia at the SEC public reference room at 100 F Street, N.E., Washington, D.C. 20549. Please call the SEC at 1-800-SEC-0330 for …
Did you find out everything you wanted about Myokardia Inc Headquarters?
We are sure that the information collected for you about Myokardia Inc Headquarters turned out to be more than enough.
